Intercept Pharmaceuticals Inc (ICPT) is near the top in its industry group according to InvestorsObserver. ICPT gets an overall rating of 72. That means it scores higher than 72 percent of stocks. Intercept Pharmaceuticals Inc gets a 83 rank in the Biotechnology industry. Biotechnology is number 8 out of 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 72 means the stock is more attractive than 72 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Intercept Pharmaceuticals Inc (ICPT) stock is trading at $81.86 as of 10:41 AM on Tuesday, Apr 21, a loss of -$0.75, or -0.91% from the previous closing price of $82.61. The stock has traded between $80.53 and $83.30 so far today. Volume today is less active than usual. So far 80,863 shares have traded compared to average volume of 667,682 shares.

To see InvestorsObserver's Sentiment Score for Intercept Pharmaceuticals Inc click here.

View post:
Where Does Intercept Pharmaceuticals Inc (ICPT) Stock Fall in the Biotechnology Field? - InvestorsObserver